Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver

Detalhes bibliográficos
Autor(a) principal: Alves, Claudia Cristina [UNIFESP]
Data de Publicação: 2017
Outros Autores: Waitzberg, Dan Linetzky, Andrade, Laila Santos de [UNIFESP], Aguiar, Lais dos Santos [UNIFESP], Reis, Milene Barcelos [UNIFESP], Guanabara, Camila Chaves [UNIFESP], Aguiar, Odair [UNIFESP], Ribeiro, Daniel Araki [UNIFESP], Sala, Priscila
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://dx.doi.org/10.3389/fmicb.2017.02010
https://repositorio.unifesp.br/handle/11600/57139
Resumo: Background and aims: Non-alcoholic fatty liver disease (NAFLD) is characterized by the presence of fat in hepatocytes because of decreased β-oxidation and increased lipogenesis. Prebiotics, probiotics, and synbiotic have modulatory effects on intestinal microbiota and may influence the gut-liver axis. Our aim was to evaluate the effects of prebiotic, probiotics, and synbiotic on liver histopathology and gene expression related to β-oxidation and lipogenesis after hypercholesterolemia. Methods: Wistar male adult rats (n = 40) were submitted to hypercholesterolemic conditions (HPC) (60 days). On Day 30 of HPC, rats were subdivided in 5 groups: negative control (NC): without HPC + Gv (distilled water); positive control (PC): with HPC + Gv (distilled water); prebiotic (PRE): HPC + Gv with prebiotic (Fiber FOS®); probiotic (PRO): HPC + Gv with probiotic strains Gv (Probiatop®); and synbiotic (SYN): HPC + Gv with synbiotic (Simbioflora®). All rats were sacrificed on Day 30 post-treatment. Blood was collected to verify total serum cholesterol, and liver tissue was sampled to verify histopathological changes and gene expression. Gene expression related to ß-oxidation (PPAR-α and CPT-1) and lipogenesis (SREBP-1c, FAS and ME) was evaluated in liver tissue using RT-qPCR. Results: PC had higher cholesterol levels when compared to NC. PRE and SYN rats had lower cholesterol levels than PC. PC rats showed more histopathological changes than NC rats; PRE and SYN rats showed fewer alterations than PC rats. PPAR-α was expressed at higher levels in SYN and PC rats compared with PRE and PRO rats. CPT-1 expression was similar in all groups. SREBP-1c was expressed at higher levels in PC rats compared with NC rats; levels were lower in SYN rats compared with PRO rats; levels were lower in PRE rats compared with PC and PRO rats. FAS was expressed at lower levels in PRE rats compared with SYN rats. ME expression was lower in PC rats compared with NC rats. Conclusion: Prebiotic and synbiotic supplementation improve hepatic alterations related to hypercholesterolemia. These changes appear to be mediated by altered expression of genes related to β-oxidation and lipogenesis.
id UFSP_cc29a2248b4d543842539130321a4195
oai_identifier_str oai:repositorio.unifesp.br/:11600/57139
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat LiverCholesterol dietSteatosisRatsPrebioticProbioticSynbioticGene expressionBackground and aims: Non-alcoholic fatty liver disease (NAFLD) is characterized by the presence of fat in hepatocytes because of decreased β-oxidation and increased lipogenesis. Prebiotics, probiotics, and synbiotic have modulatory effects on intestinal microbiota and may influence the gut-liver axis. Our aim was to evaluate the effects of prebiotic, probiotics, and synbiotic on liver histopathology and gene expression related to β-oxidation and lipogenesis after hypercholesterolemia. Methods: Wistar male adult rats (n = 40) were submitted to hypercholesterolemic conditions (HPC) (60 days). On Day 30 of HPC, rats were subdivided in 5 groups: negative control (NC): without HPC + Gv (distilled water); positive control (PC): with HPC + Gv (distilled water); prebiotic (PRE): HPC + Gv with prebiotic (Fiber FOS®); probiotic (PRO): HPC + Gv with probiotic strains Gv (Probiatop®); and synbiotic (SYN): HPC + Gv with synbiotic (Simbioflora®). All rats were sacrificed on Day 30 post-treatment. Blood was collected to verify total serum cholesterol, and liver tissue was sampled to verify histopathological changes and gene expression. Gene expression related to ß-oxidation (PPAR-α and CPT-1) and lipogenesis (SREBP-1c, FAS and ME) was evaluated in liver tissue using RT-qPCR. Results: PC had higher cholesterol levels when compared to NC. PRE and SYN rats had lower cholesterol levels than PC. PC rats showed more histopathological changes than NC rats; PRE and SYN rats showed fewer alterations than PC rats. PPAR-α was expressed at higher levels in SYN and PC rats compared with PRE and PRO rats. CPT-1 expression was similar in all groups. SREBP-1c was expressed at higher levels in PC rats compared with NC rats; levels were lower in SYN rats compared with PRO rats; levels were lower in PRE rats compared with PC and PRO rats. FAS was expressed at lower levels in PRE rats compared with SYN rats. ME expression was lower in PC rats compared with NC rats. Conclusion: Prebiotic and synbiotic supplementation improve hepatic alterations related to hypercholesterolemia. These changes appear to be mediated by altered expression of genes related to β-oxidation and lipogenesis.Univ Fed Sao Paulo, Dept Biosci, Santos, BrazilUniv Sao Paulo, Dept Gastroenterol, Sch Med, Sao Paulo, BrazilUniv Fed Sao Paulo, Nutr Grad, Santos, BrazilUniv Fed Sao Paulo, Dept Biosci, Santos, BrazilUniv Fed Sao Paulo, Nutr Grad, Santos, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FAPESP: 2011/50289-1Frontiers Media Sa2020-08-04T13:39:49Z2020-08-04T13:39:49Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion-application/pdfhttps://dx.doi.org/10.3389/fmicb.2017.02010Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017.10.3389/fmicb.2017.02010WOS000413105800001.pdf1664-302Xhttps://repositorio.unifesp.br/handle/11600/57139WOS:000413105800001engFrontiers In MicrobiologyLausanneinfo:eu-repo/semantics/openAccessAlves, Claudia Cristina [UNIFESP]Waitzberg, Dan LinetzkyAndrade, Laila Santos de [UNIFESP]Aguiar, Lais dos Santos [UNIFESP]Reis, Milene Barcelos [UNIFESP]Guanabara, Camila Chaves [UNIFESP]Aguiar, Odair [UNIFESP]Ribeiro, Daniel Araki [UNIFESP]Sala, Priscilareponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-28T01:11:51Zoai:repositorio.unifesp.br/:11600/57139Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-28T01:11:51Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
title Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
spellingShingle Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
Alves, Claudia Cristina [UNIFESP]
Cholesterol diet
Steatosis
Rats
Prebiotic
Probiotic
Synbiotic
Gene expression
title_short Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
title_full Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
title_fullStr Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
title_full_unstemmed Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
title_sort Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
author Alves, Claudia Cristina [UNIFESP]
author_facet Alves, Claudia Cristina [UNIFESP]
Waitzberg, Dan Linetzky
Andrade, Laila Santos de [UNIFESP]
Aguiar, Lais dos Santos [UNIFESP]
Reis, Milene Barcelos [UNIFESP]
Guanabara, Camila Chaves [UNIFESP]
Aguiar, Odair [UNIFESP]
Ribeiro, Daniel Araki [UNIFESP]
Sala, Priscila
author_role author
author2 Waitzberg, Dan Linetzky
Andrade, Laila Santos de [UNIFESP]
Aguiar, Lais dos Santos [UNIFESP]
Reis, Milene Barcelos [UNIFESP]
Guanabara, Camila Chaves [UNIFESP]
Aguiar, Odair [UNIFESP]
Ribeiro, Daniel Araki [UNIFESP]
Sala, Priscila
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Alves, Claudia Cristina [UNIFESP]
Waitzberg, Dan Linetzky
Andrade, Laila Santos de [UNIFESP]
Aguiar, Lais dos Santos [UNIFESP]
Reis, Milene Barcelos [UNIFESP]
Guanabara, Camila Chaves [UNIFESP]
Aguiar, Odair [UNIFESP]
Ribeiro, Daniel Araki [UNIFESP]
Sala, Priscila
dc.subject.por.fl_str_mv Cholesterol diet
Steatosis
Rats
Prebiotic
Probiotic
Synbiotic
Gene expression
topic Cholesterol diet
Steatosis
Rats
Prebiotic
Probiotic
Synbiotic
Gene expression
description Background and aims: Non-alcoholic fatty liver disease (NAFLD) is characterized by the presence of fat in hepatocytes because of decreased β-oxidation and increased lipogenesis. Prebiotics, probiotics, and synbiotic have modulatory effects on intestinal microbiota and may influence the gut-liver axis. Our aim was to evaluate the effects of prebiotic, probiotics, and synbiotic on liver histopathology and gene expression related to β-oxidation and lipogenesis after hypercholesterolemia. Methods: Wistar male adult rats (n = 40) were submitted to hypercholesterolemic conditions (HPC) (60 days). On Day 30 of HPC, rats were subdivided in 5 groups: negative control (NC): without HPC + Gv (distilled water); positive control (PC): with HPC + Gv (distilled water); prebiotic (PRE): HPC + Gv with prebiotic (Fiber FOS®); probiotic (PRO): HPC + Gv with probiotic strains Gv (Probiatop®); and synbiotic (SYN): HPC + Gv with synbiotic (Simbioflora®). All rats were sacrificed on Day 30 post-treatment. Blood was collected to verify total serum cholesterol, and liver tissue was sampled to verify histopathological changes and gene expression. Gene expression related to ß-oxidation (PPAR-α and CPT-1) and lipogenesis (SREBP-1c, FAS and ME) was evaluated in liver tissue using RT-qPCR. Results: PC had higher cholesterol levels when compared to NC. PRE and SYN rats had lower cholesterol levels than PC. PC rats showed more histopathological changes than NC rats; PRE and SYN rats showed fewer alterations than PC rats. PPAR-α was expressed at higher levels in SYN and PC rats compared with PRE and PRO rats. CPT-1 expression was similar in all groups. SREBP-1c was expressed at higher levels in PC rats compared with NC rats; levels were lower in SYN rats compared with PRO rats; levels were lower in PRE rats compared with PC and PRO rats. FAS was expressed at lower levels in PRE rats compared with SYN rats. ME expression was lower in PC rats compared with NC rats. Conclusion: Prebiotic and synbiotic supplementation improve hepatic alterations related to hypercholesterolemia. These changes appear to be mediated by altered expression of genes related to β-oxidation and lipogenesis.
publishDate 2017
dc.date.none.fl_str_mv 2017
2020-08-04T13:39:49Z
2020-08-04T13:39:49Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://dx.doi.org/10.3389/fmicb.2017.02010
Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017.
10.3389/fmicb.2017.02010
WOS000413105800001.pdf
1664-302X
https://repositorio.unifesp.br/handle/11600/57139
WOS:000413105800001
url https://dx.doi.org/10.3389/fmicb.2017.02010
https://repositorio.unifesp.br/handle/11600/57139
identifier_str_mv Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017.
10.3389/fmicb.2017.02010
WOS000413105800001.pdf
1664-302X
WOS:000413105800001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Frontiers In Microbiology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
application/pdf
dc.coverage.none.fl_str_mv Lausanne
dc.publisher.none.fl_str_mv Frontiers Media Sa
publisher.none.fl_str_mv Frontiers Media Sa
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268379620442112